A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Aktis Oncology, Inc.
Aktis Oncology, Inc.
ViroMissile, Inc.
Tizona Therapeutics, Inc
IDEAYA Biosciences
SN BioScience
Oscotec Inc.
Novartis
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Memgen, Inc.
Exelixis
Genentech, Inc.
Columbia University
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Xencor, Inc.
Celldex Therapeutics
Ikena Oncology
Emory University
Fate Therapeutics
Mayo Clinic
Fate Therapeutics
Prelude Therapeutics
Mabpro, a.s.
Quadriga Biosciences, Inc.
Xencor, Inc.
Hoffmann-La Roche
Ludwig Institute for Cancer Research
Imperial College London
Silverback Therapeutics
AbbVie
Incyte Corporation
MacroGenics
Weill Medical College of Cornell University
ISU Abxis Co., Ltd.
Novartis
Novartis
Tocagen Inc.
University of Wisconsin, Madison
Ipsen
IGF Oncology, LLC
University of Illinois at Chicago
Takara Bio Inc.
Inovio Pharmaceuticals
Synermore Biologics Co., Ltd.
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Celldex Therapeutics
Merrimack Pharmaceuticals
University Health Network, Toronto